Article & News

Gubba Group
Morepen to launch new fatty lever drug ‘Resmetirom’

Morepen Laboratories Ltd. has got clearance from Subject Expert Committee (‘SEC’) of Central Drugs Standard Control Organization (CDSCO) to conduct Bioequivalence (‘BE’) studies for Resmetirom